1. In patients with advanced, platinum-resistant ovarian cancer, combination therapy of a tyrosine kinase inhibitor, pazopanib, with paclitaxel significantly increased...

1. In a phase III, open-labelled trial of over 340 patients with localized prostate cancer treated with high-dose radiation, long-term...

1. In a phase III trial of over 600 patients with good-risk ductal carcinoma in-situ (DCIS) of the breast, adjuvant...

1. In a cohort of 98 patients diagnosed with pancreatic adenocarcinoma who underwent surgical resection, high levels of hypoxia-inducible factor...

1. In a retrospective review of over 30 000 prostate cancer patients, adding radiotherapy to androgen deprivation therapy (ADT) was associated...

1. Patients with cancer anorexia-cachexia syndrome who received anamorelin gained significantly more lean muscle mass compared to the placebo group....

1. Analysis of health care claims data demonstrated significantly reduced hypofractionated whole breast irradiation (WBI) utilization in the United States...

1. A total of 14.6% of patients with triple negative breast cancers were found to have deleterious mutations in cancer...

1. A single-cycle of adjuvant bleomycin, etoposide, and cisplatin (BEP) after orchiectomy reduces the relapse rate of stage I non-seminomatous...

1. Patients with advanced EGFR-associated non-small-cell lung cancer treated with dacomitinib had increased progression-free survival as compared to those without...